Intermediate-term Outcomes of Glaucoma Drainage Device Implantation in Adults of Advanced Age.

Q3 Medicine Journal of Current Glaucoma Practice Pub Date : 2024-10-01 Epub Date: 2025-01-20 DOI:10.5005/jp-journals-10078-1454
Mark Werner, Stephanie Byun, Rebecca Shin, Katherine Freeman
{"title":"Intermediate-term Outcomes of Glaucoma Drainage Device Implantation in Adults of Advanced Age.","authors":"Mark Werner, Stephanie Byun, Rebecca Shin, Katherine Freeman","doi":"10.5005/jp-journals-10078-1454","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim and background: </strong>To compare outcomes of glaucoma tube shunt surgery in patients aged 85 years and older to younger adults.</p><p><strong>Methods: </strong>Medical records were reviewed involving 207 consecutive tube shunt surgeries performed by one surgeon between 2013 and 2019. Baseline characteristics between group A (adults aged <85) and group B (aged ≥85) were compared. Changes from baseline to 12 months were compared between groups.</p><p><strong>Results: </strong>One-year follow-up was completed for 80 of 125 eyes (group A) and 49 of 82 eyes (group B). Intraocular pressure (IOP) and number of medications were statistically significantly reduced at 12 months, with no significant difference between groups (group A: 33.1 ± 11.2 → 13.8 ± 4.5 mm Hg, group B: IOP 33.6 ± 10.2 → 14.0 ± 4.3 mm Hg; <i>p</i> = 0.7168; group A: 3.2 ± 1.2 → 1.6 ± 1.3 meds, group B: 3.2 ± 1.1 → 1.8 ± 1.4 meds; <i>p</i> = 0.8404). Success rate was 109/128 (85.1%) overall, with no significant difference between groups (<i>p</i> = 0.2625). LogMAR visual acuity (VA) significantly worsened in group B only (group A: 0.68 ± 0.59 preop → 0.67 ± 0.58 postop; group B: 0.79 ± 0.60 preop → 0.98 ± 0.73 postop; <i>p</i> = 0.0006). More older patients lost ≥0.25 logMAR VA (group A: 11/80 = 14% vs group B: 17/49 = 35%; <i>p</i> = 0.0051).</p><p><strong>Conclusion: </strong>For advanced-age patients, tube shunt surgery provides good intraocular pressure control, with a higher, though acceptable, risk of loss of VA.</p><p><strong>Clinical significance: </strong>Tube shunts may be undertaken in patients of advanced age at high risk of vision loss from glaucoma.</p><p><strong>How to cite this article: </strong>Werner M, Byun S, Shin R, <i>et al</i>. Intermediate-term Outcomes of Glaucoma Drainage Device Implantation in Adults of Advanced Age. J Curr Glaucoma Pract 2024;18(4):162-170.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"18 4","pages":"162-170"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11915357/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Current Glaucoma Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10078-1454","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Aim and background: To compare outcomes of glaucoma tube shunt surgery in patients aged 85 years and older to younger adults.

Methods: Medical records were reviewed involving 207 consecutive tube shunt surgeries performed by one surgeon between 2013 and 2019. Baseline characteristics between group A (adults aged <85) and group B (aged ≥85) were compared. Changes from baseline to 12 months were compared between groups.

Results: One-year follow-up was completed for 80 of 125 eyes (group A) and 49 of 82 eyes (group B). Intraocular pressure (IOP) and number of medications were statistically significantly reduced at 12 months, with no significant difference between groups (group A: 33.1 ± 11.2 → 13.8 ± 4.5 mm Hg, group B: IOP 33.6 ± 10.2 → 14.0 ± 4.3 mm Hg; p = 0.7168; group A: 3.2 ± 1.2 → 1.6 ± 1.3 meds, group B: 3.2 ± 1.1 → 1.8 ± 1.4 meds; p = 0.8404). Success rate was 109/128 (85.1%) overall, with no significant difference between groups (p = 0.2625). LogMAR visual acuity (VA) significantly worsened in group B only (group A: 0.68 ± 0.59 preop → 0.67 ± 0.58 postop; group B: 0.79 ± 0.60 preop → 0.98 ± 0.73 postop; p = 0.0006). More older patients lost ≥0.25 logMAR VA (group A: 11/80 = 14% vs group B: 17/49 = 35%; p = 0.0051).

Conclusion: For advanced-age patients, tube shunt surgery provides good intraocular pressure control, with a higher, though acceptable, risk of loss of VA.

Clinical significance: Tube shunts may be undertaken in patients of advanced age at high risk of vision loss from glaucoma.

How to cite this article: Werner M, Byun S, Shin R, et al. Intermediate-term Outcomes of Glaucoma Drainage Device Implantation in Adults of Advanced Age. J Curr Glaucoma Pract 2024;18(4):162-170.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高龄成人青光眼引流装置植入术的中期疗效。
目的与背景:比较85岁及以上青光眼管分流手术与年轻人的预后。方法:回顾2013年至2019年由一名外科医生连续实施的207例分流手术的病历。结果:125只眼中有80只(A组)完成1年随访,82只眼中有49只(B组)完成1年随访,12个月时眼压(IOP)和用药次数均有统计学意义降低,组间差异无统计学意义(A组:33.1±11.2→13.8±4.5 mm Hg, B组:IOP 33.6±10.2→14.0±4.3 mm Hg;P = 0.7168;A组:3.2±1.2→1.6±1.3用药,B组:3.2±1.1→1.8±1.4用药;P = 0.8404)。总体成功率为109/128(85.1%),两组间差异无统计学意义(p = 0.2625)。只有B组LogMAR视力(VA)明显恶化(A组:术前0.68±0.59→术后0.67±0.58;B组:术前0.79±0.60→术后0.98±0.73;P = 0.0006)。≥0.25 logMAR VA的老年患者较多(A组:11/80 = 14%,B组:17/49 = 35%;P = 0.0051)。结论:高龄患者行分流管手术能很好地控制眼压,但有较高的va丧失风险,但可接受。临床意义:高龄且青光眼视力丧失风险高的患者可行分流管手术。引用方式:Werner M, Byun S, Shin R,等。高龄成人青光眼引流装置植入术的中期疗效。中华青光眼杂志;2009;18(4):562 - 561。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Current Glaucoma Practice
Journal of Current Glaucoma Practice Medicine-Ophthalmology
CiteScore
1.00
自引率
0.00%
发文量
38
期刊最新文献
Risk Factors and Genetic Markers Associated with the Development and Progression of Glaucoma: A Review. Bridging Genomics and Practice: Rethinking Genetic Counseling in Glaucoma. Impact of Postoperative Intraocular Pressure Spikes on Outcomes Following Goniotomy: A Comparative Study of Surgical Techniques. Glaucoma Risk Reduction as a Secondary Benefit of Glucagon-like Peptide-1 Receptor Agonists: A Review of Emerging Evidence. Neovascularization of the Iris/Angle in Primary Angle Closure Glaucoma: A Distinct Entity!
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1